Send me a link:

*Text messaging rates may apply.

 Dow Up 0.36% Nasdaq Up 0.71%

Intercept Pharmaceuticals, Inc. (ICPT)

-NasdaqGS
223.00 Up 4.86(2.23%) 3:59PM EDT
|After Hours : 224.00 Up 1.00 (0.45%) 7:27PM EDT
Prev Close:218.14
Open:219.49
Bid:221.67 x 300
Ask:224.00 x 100
1y Target Est:454.45
Beta:-3.02
Earnings Date:Aug 11 - Aug 15 (Est.)
Day's Range:219.00 - 226.00
52wk Range:42.41 - 497.00
Volume:247,449
Avg Vol (3m):479,543
Market Cap:4.70B
P/E (ttm):N/A
EPS (ttm):-16.80
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
ICPTUp 2.23%4.70B
AZNUp 0.19%94.76B
SLXPUp 0.86%8.32B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):2,836.61
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-14.82
Quarterly EPS Est (Jun-14) :-0.12
Mean Recommendation*:1.9
PEG Ratio (5 yr expected):3.49

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Intercept Pharmaceuticals, Inc., a development stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics to treat chronic liver and intestinal diseases utilizing its proprietary bile acid chemistry. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback